Boston University
Developing a sirtuin-1 activity assay to test novel sirt1 activators in a murine vascular smooth muscle cell model of Marfan syndrome
Abstract
dc:description.abstractMarfan syndrome (MFS) is a disorder of the connective tissue characterized by a lack of fibrillin-1 (FBN1). Reduced levels of FBN1 leads to widespread impacts on the cardiovascular, ocular, and skeletal systems. One of the most dangerous clinical manifestations of MFS is reduced health of vascular smooth muscle, particularly of the aorta. This can lead to abnormal dilatations of the aorta, called aortic aneurysm, which can progress into life-threatening aortic dissections and ruptures. Sirtuin-1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase. SIRT1 has been shown to provide antioxidant and anti-inflammatory effects, to protect against the effects of aging and to mediate some of the benefits of calorie restriction. It was postulated that SIRT1 could become a potential therapeutic target against aortic aneurysms and possibly other vascular diseases. The goal of this thesis was twofold: (1) to optimize an enzyme-linked immunosorbent assay (ELISA) to test the effect of novel molecules on activating SIRT1 and (2) to develop a model of MFS in mouse vascular smooth muscle cells using silencing RNA to reduce FBN1, on which to test SRT1 activators.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Hardy, Tyler
- Advisors dc:contributor.advisor
-
- Seta, Francesca
- Spencer, Jean L.
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- Attribution 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/52308